CINECA IRIS Institutional Research Information System

ARPICCO, Silvia Maria Angela

ARPICCO, Silvia Maria Angela  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 221 (tempo di esecuzione: 0.051 secondi).
Titolo Data di pubblicazione Autore(i) File
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 1998 M. CERUTI; F. ROCCO; F. VIOLA; G. BALLIANO; P. MILLA; S. ARPICCO; L. CATTEL
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. 2014 Paola Milla; Chiara Fiorito; Francesco Soria; Silvia Arpicco; Luigi Cattel; Paolo Gontero
A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions 2001 CATTEL L; RECALENDA V; AIROLDI M; TAGINI V; ARPICCO S; BRUSA P; BUMMA C
Advances in anticancer antibody-drug conjugates and immunotoxins. 2014 F. Dosio; B. Stella; S. Cerioni; D. Gastaldi; S. Arpicco
An ex vivo experimental system to track fluorescent nanoparticles inside skeletal muscle 2023 Calderan, Laura; Carton, Flavia; Andreana, Ilaria; Bincoletto, Valeria; Arpicco, Silvia; Stella, Barbara; Malatesta, Manuela
Antibiotics Removal during Continuous Renal Replacement Therapy in Septic Shock Patients: Mixed Modality Versus “Expanded Haemodialysis” 2024 Ferrari, Fiorenza; Milla, Paola; Sartori, Marco; Zanza, Christian; Tesauro, Manfredi; Longhitano, Yaroslava; De Silvestri, Annalisa; Abbruzzese, Chiara; De Rosa, Silvia; Lassola, Sergio; Samoni, Sara; Brendolan, Alessandra; Zanella, Monica; Scaravilli, Vittorio; Grasselli, Giacomo; Arpicco, Silvia; Ronco, Claudio
Anticancer prodrugs: an overview of major strategies and recent developments. 2011 ARPICCO S; DOSIO F; STELLA B; CATTEL L
ANTITUMORAL ACTIVITY OF LIPOSOMES AND IMMUNOLIPOSOMES CONTAINING 5-FLUOROURIDINE PRODRUGS 1997 P. CROSASSO; P. BRUSA; F. DOSIO; S. ARPICCO; D. PACCHIONI; F. SCHUBER; L. CATTEL
Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid 2008 PASUT G; CANAL F; VIA LD; ARPICCO S; VERONESE FA; SCHIAVON O
Biological characterisation of folic acid-conjugated nanoparticles in cellular models 2001 B. Stella; V. Marsaud; S. Arpicco; M.T. Peracchia; G. Géraud; M.L. Immordino; L. Cattel; P. Couvreur; M. Renoir
Biological characterization of folic acid-conjugated poly(H(2)NPEGCA-co-HDCA) nanoparticles in cellular models 2007 STELLA B; MARSAUD V; ARPICCO S; GERAUD G; CATTEL L; COUVREUR P; RENOIR JM
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain 2021 Stella B.; Baratta F.; Della Pepa C.; Arpicco S.; Gastaldi D.; Dosio F.
Caratterizzazione di nanoparticelle di polialchilcianoacrilato coniugate con l’acido folico 2000 B. Stella; S. Arpicco; M.T. Peracchia; D. Desmaële; J. Hoebeke; M.L. Immordino; J. d’Angelo; P. Couvreur; L. Cattel
Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici. 2000 Cattel L.; Arpicco S.; Ceruti M.; Rocco F.; Dosio F.; Brusa P.
Cationic liposomes contaiing a DOPE-hyaluronate conjugate for gene delivery 2008 S. Arpicco; C. Surace; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal
Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery 2007 C. Surace; S. Arpicco; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal
Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery 2008 C. Surace; S. Arpicco; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal
Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery 2007 C. Surace; S. Arpicco; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal
Cationic liposomes containing a DOPE-hyaluronate conjugate for gene delivery. 2010 S. Arpicco
CD44 targeted nanotechnologies. 2013 E. Fattal; S. Arpicco; M. Palmieri; H. Hillaireau